Category Archives: Polaris News

POLARISqb and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service
POLARISqb, the first company in the world to develop a drug discovery engine that utilizes the optimization power of quantum computing, announced that it has signed an MOU with Syntekabio (KOSDAQ: 226330), an Artificial Intelligence (AI) based drug development company. The partnership, which will combine the companies’ vanguard drug research platforms, will provide a collaborative…
Read more
White Paper on QuADD shows Marked Advantage Versus Conventional Library Builds
Polaris Quantum Biotech (POLARISqb) leverages quantum computing to accelerate drug discovery, revolutionizing the way that molecular drug design is accomplished. The company released a white paper on the advantages of using the POLARISqb platform Quantum-Aided Drug Design (QuADD) for library generation. An enriched starting library of diverse and drug-like molecules increases the probability of quickly…
Read more
POLARISqb Announces Quantum SaaS: Quantum Aided Drug Design (QuADD)
POLARISqb, an industry leader in accelerating drug discovery using quantum computing, is excited to announce Quantum-Aided Drug Design (QuADD). QuADD is a subscription-based SaaS platform that quickly identifies a library of top candidate molecules for drug targets. In order to find a new preclinical lead, the first step is to build a library of small…
Read more